4//SEC Filing
Johnson John Paul 4
Accession 0001628908-22-000118
CIK 0001628908other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 6:04 PM ET
Size
5.2 KB
Accession
0001628908-22-000118
Insider Transaction Report
Form 4
Johnson John Paul
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2022-08-17$34.11/sh−18,434$628,784→ 168,329 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.11 to $34.22, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001782040
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 6:04 PM ET
- Size
- 5.2 KB